Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Why Chembio Diagnostics Shares Are Falling

Chembio Diagnostics Inc (NASDAQ:CEMI) shares are trading lower by 12.4% at $0.81 after the company reported worse-than-expected fourth-quarter adjusted EPS results.

Chembio Diagnostics reported quarterly losses of 32 cents per share which missed the analyst consensus estimate of a loss of 20 cents per share by 60 percent. Chembio Diagnostics also reported quarterly sales of $20.57 million which beat the analyst consensus estimate of $13.55 million by 52%. This sales figure represents a 101% increase over sales of $10.23 million in the same period last year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.